News

Seattle Genetics has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. The company has said that Brentuximab vedotin is

Zargis Medical has started selling Zargis Cardioscan heart sound analysis software, along with 3M’s just-released Bluetooth-enabled 3M Littmann Electronic Stethoscope Model 3200, as part of its previously announced

CSL Biotherapies has announced the initiation of the company’s first US clinical trials of its candidate Influenza A/H1N1 2009 vaccine. The studies are expected to determine the safety

Osteologix, a Virginia-based biopharmaceutical company working in the area of musculoskeletal diseases, such as osteoporosis, has announced that the Japan Patent Office (JPO) has issued a Decision to

CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, has announced that study results demonstrated that arimoclomol exhibited both statistically significant

Santaris has signed a multi-year worldwide strategic alliance with Shire to discover and develop new RNA-based medicines to treat rare genetic disorders. The alliance will use Santaris’ proprietary

Karolinska has reported that Xspray Microparticles has launched a GMP production facility in Malmo, Sweden. In addition to offering particle development and characterization services, XSpray can now provide

PCI Biotech (PCI) has initiated the phase I/II trial with the first patient treatment with its lead candidate, Amphinex. PCI’s proprietary photosensitiser Amphinex is in the study combined

Myoderm, a pharmaceutical supplier of comparator drugs for clinical research and clinical trials, has expanded its portfolio to include Distribution Management Services. Reportedly, this new capability provides their